Even though we at Plantine have unique proprietary full-spectrum and water-soluble products, masking both taste and aroma, while still being packed with phytocannabinoids and the rest of the goodness from the plant, we are naturally not alone when it comes to targeting the food market.
We are fortunate to see a rising trend in interest by food producers who wants infuse or add hemp constituents or extracts, to their existing portfolios. We at Plantine welcome such developments and we are ready to cater for this particular type of request, that typically focuses on the need to add the full spectrum from hemp, while still controlling taste and aroma in the final product. This can be hard with conventional hemp and cbd extracts, as they reveal their presence in any formula, with a strong taste and aroma, that for some, is undesirable.
This is naturally a reason to look into our portfolio of water-soluble full spectrum options, which eliminates all these downsides of conventional extracts, while keeping the benefits. Our options are naturally lightyears ahead of mere isolates, as they can hardly be compared or considered to be genuine food products or health food product, but rather a pharmaceutical or novel food.
Another company that has recently announced that it is entering the food market with a cannabis related beer and tonnic, is CLV Frontier Brands Pty Ltd, which is co-owned by companies like UK based Creso Pharma, Canadian TSX Venture Inc and LGC Capital.
In an article by HempToday.net it says:
CLV Frontier Brands Pty Ltd says it will begin marketing cannabis-flavored beers and tonics in Europe and Canada this summer, Creso Pharma, a partner in the three-way partnership, has announced.
The new drinks contain terpenes, which carry the aroma and flavor of cannabis without any accompanying THC or cannabinoids.
Creso, UK-based Baltic Beer Company Ltd. and Canadian TSX Venture incorporated LGC Capital are equal one-third partners in CLV.
‘Significant’ sales envisioned
“We see CLV as an exciting business partnership that we believe can add significant sales revenues to Creso Pharma over the coming years,” Dr. Miri Halperin Wernli, Co-Founder and CEO at Creso Pharma, said in a release.
Terpenes, which are derived from cannabis and other plants, have a range of applications in food, cosmetics, pharmaceuticals and biotechnology. Those contained in the products under development by CLV are extracted from various plant sources, all of which are food-grade, 100% natural and non-GMO, according to Creso. The terpenes are introduced to beer at the post-fermentation stage in much the same manner as hop extracts are added.”